Virtus LifeSci Biotech Products ETF
18 hedge funds and large institutions have $13.1M invested in Virtus LifeSci Biotech Products ETF in 2017 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
6% more funds holding
Funds holding: 17 → 18 (+1)
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$525K | |
| 2 | +$196K | |
| 3 | +$116K | |
| 4 |
LPL Financial
San Diego,
California
|
+$66K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$62.6K |
Top Sellers
| 1 | -$398K | |
| 2 | -$263K | |
| 3 | -$9.13K | |
| 4 |
AG
Advisor Group
Phoenix,
Arizona
|
-$1K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$568 |